Mark J Levin insider trades: Jounce Therapeutics (JNCE) stock buys and sales
Trades on the price chart
Daily close, with an arrow on each day they bought or sold
Companies
Where Mark reports to the SEC
and 15 more companies
Open-market buys and sales
73 trades reported on SEC Form 4, newest first
| Date | Stock | Type | Shares | Price | Value | Holding | Reported |
|---|---|---|---|---|---|---|---|
| Nov 12, 2021 | JNCE | ↓ Sell | 1,900,000 | $8.38 | $15.9M | Direct | Nov 16, 2021 (4d) |
| Jun 4, 2021 | RVMD | ↓ Sell | 543,113 | $30.21 | $16.4M | Direct | Jun 7, 2021 (3d) |
| May 26, 2021 | RVMD | ↓ Sell | 1,366,204 | $30.57 | $41.8M | Direct | May 27, 2021 (1d) |
| May 25, 2021 | JNCE | ↓ Sell | 552,520 | $8.00 | $4.4M | Direct | May 27, 2021 (2d) |
| Mar 1, 2021 | JNCE | ↓ Sell | 1,450,000 | $11.75 | $17.0M | Direct | Mar 3, 2021 (2d) |
| Jan 14, 2021 | RLAY | ↓ Sell | 2,811,197 | $40.74 | $114.5M | Indirect | Jan 14, 2021 (0d) |
| Jan 13, 2021 | RLAY | ↓ Sell | 2,811,197 | $40.06 | $112.6M | Direct | Jan 14, 2021 (1d) |
| Nov 19, 2020 | JNCE | ↓ Sell | 15,000 | $7.00 | $105K | Direct | Nov 23, 2020 (4d) |
| Nov 17, 2020 | JNCE | ↓ Sell | 15,000 | $7.25 | $109K | Direct | Nov 19, 2020 (2d) |
| Jul 22, 2019 | FULC | ↑ Buy | 81,250 | $16.00 | $1.3M | By fund | Jul 22, 2019 (0d) |
| Jul 23, 2018 | CNST | ↑ Buy | 266,667 | $15.00 | $4.0M | Direct | Jul 24, 2018 (1d) |
| Jan 3, 2018 | MYOK | ↓ Sell | 816,326 | $42.00 | $34.3M | Direct | Jan 5, 2018 (2d) |
| Nov 6, 2017 | ALNA | ↑ Buy | 215,000 | $14.00 | $3.0M | Direct | Nov 6, 2017 (0d) |
| Sep 26, 2017 | MYOK | ↓ Sell | 601,400 | $43.00 | $25.9M | Direct | Sep 27, 2017 (1d) |
| Sep 11, 2017 | MYOK | ↓ Sell | 221,250 | $41.30 | $9.1M | Direct | Sep 12, 2017 (1d) |
| Mar 27, 2017 | CTMX | ↓ Sell | 1,650,000 | $17.39 | $28.7M | Direct | Mar 27, 2017 (0d) |
| Mar 16, 2017 | BPMC | ↓ Sell | 30,000 | $40.88 | $1.2M | Direct | Mar 20, 2017 (4d) |
| Mar 2, 2017 | GBT | ↓ Sell | 2,045,294 | $25.54 | $52.2M | Direct | Mar 6, 2017 (4d) |
| Feb 7, 2017 | BPMC | ↓ Sell | 1,000,000 | $35.27 | $35.3M | Direct | Feb 9, 2017 (2d) |
| Nov 14, 2016 | GBT | ↓ Sell | 2,000,000 | $19.36 | $38.7M | Direct | Nov 16, 2016 (2d) |
| May 16, 2016 | SAGE | ↓ Sell | 850,000 | $31.25 | $26.6M | Direct | May 18, 2016 (2d) |
| Jan 9, 2008 | MLNM | ↓ Sell | 8,100 | $15.12 | $122K | Direct | Jan 10, 2008 (1d) |
| Jan 9, 2008 | MLNM | ↓ Sell | 1,900 | $15.06 | $29K | Direct | Jan 10, 2008 (1d) |
| Jan 2, 2008 | MLNM | ↓ Sell | 7,400 | $16.17 | $120K | Direct | Jan 3, 2008 (1d) |
| Jan 2, 2008 | MLNM | ↓ Sell | 2,600 | $16.27 | $42K | Direct | Jan 3, 2008 (1d) |
| Dec 26, 2007 | MLNM | ↓ Sell | 10,000 | $15.58 | $156K | Direct | Dec 27, 2007 (1d) |
| Dec 19, 2007 | MLNM | ↓ Sell | 8,900 | $14.91 | $133K | Direct | Dec 21, 2007 (2d) |
| Dec 19, 2007 | MLNM | ↓ Sell | 1,100 | $15.06 | $17K | Direct | Dec 21, 2007 (2d) |
| Dec 12, 2007 | MLNM | ↓ Sell | 9,100 | $15.70 | $143K | Direct | Dec 13, 2007 (1d) |
| Dec 12, 2007 | MLNM | ↓ Sell | 900 | $15.54 | $14K | Direct | Dec 13, 2007 (1d) |
| Dec 5, 2007 | MLNM | ↓ Sell | 8,900 | $15.18 | $135K | Direct | Dec 6, 2007 (1d) |
| Dec 5, 2007 | MLNM | ↓ Sell | 1,100 | $15.25 | $17K | Direct | Dec 6, 2007 (1d) |
| Nov 28, 2007 | MLNM | ↓ Sell | 9,200 | $15.24 | $140K | Direct | Nov 29, 2007 (1d) |
| Nov 28, 2007 | MLNM | ↓ Sell | 800 | $15.19 | $12K | Direct | Nov 29, 2007 (1d) |
| Nov 21, 2007 | MLNM | ↓ Sell | 9,600 | $14.06 | $135K | Direct | Nov 26, 2007 (5d) |
| Nov 21, 2007 | MLNM | ↓ Sell | 400 | $14.15 | $6K | Direct | Nov 26, 2007 (5d) |
| Nov 14, 2007 | MLNM | ↓ Sell | 9,600 | $13.97 | $134K | Direct | Nov 15, 2007 (1d) |
| Nov 14, 2007 | MLNM | ↓ Sell | 400 | $14.00 | $6K | Direct | Nov 15, 2007 (1d) |
| Nov 7, 2007 | MLNM | ↓ Sell | 6,800 | $13.19 | $90K | Direct | Nov 8, 2007 (1d) |
| Nov 7, 2007 | MLNM | ↓ Sell | 2,900 | $13.05 | $38K | Direct | Nov 8, 2007 (1d) |
| Nov 7, 2007 | MLNM | ↓ Sell | 300 | $13.18 | $4K | Direct | Nov 8, 2007 (1d) |
| Oct 3, 2007 | MLNM | ↓ Sell | 10,000 | $10.26 | $103K | Direct | Oct 4, 2007 (1d) |
| Sep 26, 2007 | MLNM | ↓ Sell | 10,000 | $10.15 | $102K | Direct | Sep 27, 2007 (1d) |
| Sep 19, 2007 | MLNM | ↓ Sell | 10,000 | $10.56 | $106K | Direct | Sep 20, 2007 (1d) |
| Sep 12, 2007 | MLNM | ↓ Sell | 10,000 | $10.00 | $100K | Direct | Sep 13, 2007 (1d) |
| Sep 5, 2007 | MLNM | ↓ Sell | 10,000 | $10.14 | $101K | Direct | Sep 6, 2007 (1d) |
| Aug 29, 2007 | MLNM | ↓ Sell | 10,000 | $9.76 | $98K | Direct | Aug 30, 2007 (1d) |
| Aug 22, 2007 | MLNM | ↓ Sell | 10,000 | $9.82 | $98K | Direct | Aug 23, 2007 (1d) |
| Aug 15, 2007 | MLNM | ↓ Sell | 10,000 | $10.26 | $103K | Direct | Aug 16, 2007 (1d) |
| Aug 8, 2007 | MLNM | ↓ Sell | 10,000 | $10.42 | $104K | Direct | Aug 9, 2007 (1d) |
Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.
About Mark J Levin's insider trades
Mark J Levin is a 10% owner of Jounce Therapeutics (JNCE). Since Aug 11, 2005, Mark has reported 3 open-market purchases worth $8.3M and 70 sales worth $590.5M on SEC Form 4. There have been no open-market trades in the last 12 months.
Their filings also include other transactions (46 filings), conversions (21 filings), grants and awards (14 filings), option exercises (2 filings). These aren't open-market trades and aren't counted above.
How to read insider trades
Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every JNCE insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.